Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
Francesco Paolo Cantatore,1 Nicola Maruotti,1 Addolorata Corrado,1 Domenico Ribatti2,3 1Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia Medical School, Foggia, 2Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical S...
Guardado en:
Autores principales: | Cantatore FP, Maruotti N, Corrado A, Ribatti D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/befd641cc2d2455daf343cfa3022d61f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Features of heritable disorders of connective tissue in children with acute rheumatic fever and rheumatic heart disease
por: Oksana Boyarchuk
Publicado: (2020) -
Liver involvement in rheumatic diseases
por: Joanna Podgórska, et al.
Publicado: (2020) -
COMPLEXITY OF EARLY DIAGNOSIS AND TREATMENT OF RHEUMATIC DISEASES
por: M. V. Sklyanova, et al.
Publicado: (2012) -
The challenge of screening for asymptomatic rheumatic heart disease in South Africa
por: Liesl Zühlke, et al.
Publicado: (2017) -
Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
por: Kalliopi Klavdianou, et al.
Publicado: (2021)